1. Home
  2. ROIV vs GFS Comparison

ROIV vs GFS Comparison

Compare ROIV & GFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$28.68

Market Cap

20.7B

Sector

Health Care

ML Signal

HOLD

Logo GlobalFoundries Inc.

GFS

GlobalFoundries Inc.

HOLD

Current Price

$48.57

Market Cap

24.0B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROIV
GFS
Founded
2014
2009
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
20.7B
24.0B
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
ROIV
GFS
Price
$28.68
$48.57
Analyst Decision
Strong Buy
Buy
Analyst Count
8
12
Target Price
$27.56
$45.08
AVG Volume (30 Days)
4.2M
3.9M
Earning Date
05-28-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$29,053,000.00
N/A
Revenue This Year
N/A
$7.64
Revenue Next Year
$878.32
$9.90
P/E Ratio
N/A
$29.28
Revenue Growth
N/A
N/A
52 Week Low
$9.87
$30.69
52 Week High
$30.33
$50.98

Technical Indicators

Market Signals
Indicator
ROIV
GFS
Relative Strength Index (RSI) 57.95 61.13
Support Level $26.45 $39.96
Resistance Level $30.33 $49.36
Average True Range (ATR) 0.96 2.13
MACD 0.02 0.46
Stochastic Oscillator 95.23 92.42

Price Performance

Historical Comparison
ROIV
GFS

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About GFS GlobalFoundries Inc.

GlobalFoundries is a top-five contract semiconductor manufacturer globally. It was originally the manufacturing arm of Advanced Micro Devices before it was spun out in 2009. The foundry sells chips into a range of end markets including smartphones, PCs, Internet of Things, data centers, automotive, industrial, and so on, but primarily focuses on more mature process technologies. Until 2021, the firm was privately held by Mubadala Investment, the sovereign wealth fund of the United Arab Emirates, which remains its controlling shareholder today. GlobalFoundries merged with Chartered Semiconductor Manufacturing in 2009 and acquired IBM's chipmaking business in 2015. GF is headquartered in Malta, New York, and has about 13,000 staff.

Share on Social Networks: